Detalles de la búsqueda
1.
Comparative efficacy and safety of Gla-300 versus IDegAsp in insulin-naïve people with type 2 diabetes mellitus uncontrolled on oral anti-diabetics.
Diabetes Obes Metab
; 25(9): 2495-2504, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37312665
2.
Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50.
Value Health
; 25(2): 203-214, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094793
3.
Gastrointestinal adverse events with insulin glargine/lixisenatide fixed-ratio combination versus glucagon-like peptide-1 receptor agonists in people with type 2 diabetes mellitus: A network meta-analysis.
Diabetes Obes Metab
; 23(1): 136-146, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991041
4.
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
Diabetes Obes Metab
; 22(11): 2179-2188, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700442
5.
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.
Diabetes Obes Metab
; 22(11): 2170-2178, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32627297
6.
Re: Arcuri and Americo "Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis".
Ann Hematol
; 101(7): 1599-1601, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179641
7.
Matching-adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma.
Cancer Med
; 12(7): 8005-8017, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726287
8.
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.
Rheumatol Ther
; 10(3): 539-550, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725768
9.
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
BMC Med Res Methodol
; 12: 9, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22297116
10.
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50.
Ther Adv Med Oncol
; 14: 17588359221105024, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747163
11.
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer.
Front Oncol
; 12: 1081729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082098
12.
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
Respir Med
; 191: 105991, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090688
13.
Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness.
Value Health
; 14(5): 640-6, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21839400
14.
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
J Allergy Clin Immunol Pract
; 9(6): 2461-2471.e5, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548517
15.
Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma.
J Manag Care Spec Pharm
; 27(11): 1513-1525, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351214
16.
Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis.
J Child Neurol
; 34(7): 371-381, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30803305
17.
Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis'.
Dermatol Ther (Heidelb)
; 14(3): 819-821, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366176
18.
Number needed to treat in indirect treatment comparison.
J Comp Eff Res
; 7(3): 259-269, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29537878
19.
Efficacy and safety of diclofenac in osteoarthritis: Results of a network meta-analysis of unpublished legacy studies.
Scand J Pain
; 16: 74-88, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28850416
20.
Extrapolation of Survival Curves from Cancer Trials Using External Information.
Med Decis Making
; 37(4): 353-366, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27681990